Wissenschaftliche Arbeiten

Doç. Dr. Lale Aydın Kaynar

30 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Comparative prognostic performance of ELN 2022 and ELN 2024 risk classifications in a Turkish cohort of acute myeloid leukemia patients receiving hypomethylating agents and BCL-2 inhibitors

    Acta Medica, 2026

    DOI 10.32552/actamedica.2026.1271 Frei zugänglicher VolltextQuelle: OpenAlex

  2. C-Reactive Protein-to-Albumin Ratio (CAR) as a Prognostic Biomarker in Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Therapy: A Single-Center Retrospective Cohort Study

    Hitit Medical Journal, 2026

    DOI 10.52827/hititmedj.2012111 Frei zugänglicher VolltextQuelle: OpenAlex

  3. Thrombotic and hemorrhagic complications in NPM1-mutated AML: Association with APL-like immunophenotype and impact on early mortality

    Journal of Thrombosis and Thrombolysis, 2026

    DOI 10.1007/s11239-026-03410-4 PMID 42878784 Quelle: OpenAlex

  4. Prognostic Impact of Serum Albumin Levels at Diagnosis in Patients with Chronic Lymphocytic Leukemia

    Journal of clinical medicine, 2026

    DOI 10.3390/jcm15031315 PMID 41682996 Frei zugänglicher VolltextQuelle: Europe PMC

  5. Adherence to prophylaxis in adults with hemophilia: the role of communication, self-ınfusion, and ınfusion timing

    Journal of Current Hematology & Oncology Research, 2026

    DOI 10.51271/jchor-0080 Frei zugänglicher VolltextQuelle: OpenAlex

  6. Overview of Acute Myeloid Leukemia with TP53 Mutation: Single Center, Real-Life Data

    Hitit Medical Journal, 2025

    DOI 10.52827/hititmedj.1628279 Frei zugänglicher VolltextQuelle: OpenAlex

  7. Prognostic value of hyperlactatemia and lactate clearance in septic patients with hematological malignancies

    Annals of Hematology, 2024

    DOI 10.1007/s00277-024-05977-5 PMID 39235491 6 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  8. Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2023

    DOI 10.4274/tjh.galenos.2023.2023.0194 PMID 37877113 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  9. Salvage Autologous Hematopoietic Stem Cell Transplantation Versus Chemoimmunotherapy in Relapsed Multiple Myeloma Patients After First Transplantation; Single Center Data

    Journal of Ankara University Faculty of Medicine, 2023

    DOI 10.4274/atfm.galenos.2023.83713 Frei zugänglicher VolltextQuelle: OpenAlex

  10. Is flow cytometry useful in determining central nervous system involvement in patients with hematological malignancy? Analysis with a prospective cohort

    Leukemia Research, 2023

    DOI 10.1016/j.leukres.2023.107332 PMID 37307678 7 Zitationen (OpenAlex) Quelle: OpenAlex

  11. The Effect of Granulocyte Colony-Stimulating Factor (G-CSF) on Early Complications and Graft-Versus-Host Disease (GVHD) in Allogeneic Stem Cell Transplantation (ASCT) Recipients

    Cureus, 2023

    DOI 10.7759/cureus.46105 PMID 37779681 Frei zugänglicher VolltextQuelle: OpenAlex

  12. COVID-19 Enfeksiyonunun Hematolojik Maligniteli Hastalar Üzerine Etkiler

    LLM Dergi, 2023

    DOI 10.5578/llm.20239902 Frei zugänglicher VolltextQuelle: OpenAlex

  13. Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysis

    Annals of hematology, 2022

    DOI 10.1007/s00277-022-04992-8 PMID 36195680 2 Zitationen (Europe PMC) Quelle: Europe PMC

  14. Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia

    Annals of Hematology, 2022

    DOI 10.1007/s00277-022-04835-6 PMID 35460388 8 Zitationen (OpenAlex) Quelle: OpenAlex

  15. Standart Prophylactic Granulocyte Colony Stimulating Factor Usage As A Part Of Autologous Stem Cell Transplantation Procedure

    Acta Oncologica Turcica, 2022

    DOI 10.5505/aot.2022.47113 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  16. Eltrombopag may induce bone marrow fibrosis in allogeneic hematopoietic stem cell transplant recipients with prolonged thrombocytopenia

    Leukemia Research, 2022

    DOI 10.1016/j.leukres.2022.106870 PMID 35665626 9 Zitationen (OpenAlex) Quelle: OpenAlex

  17. Gastrointestinal Sistemde Temel Semiyoloji

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.684 Frei zugänglicher VolltextQuelle: OpenAlex

  18. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

    Turkish Journal of Hematology, 2021

    DOI 10.4274/tjh.galenos.2021.2021.0287 PMID 34521187 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  19. Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis.

    PubMed Central, 2021

    PMID 34322292 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  20. Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis

    Bursa Uludag University - AVESIS, 2021

    Quelle: OpenAlex

  21. Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis

    AYBU AVESIS, 2021

    Quelle: OpenAlex

  22. Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study

    Hematology (Amsterdam, Netherlands), 2021

    DOI 10.1080/16078454.2021.1905355 PMID 33818297 9 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  23. Hematopoietic Cell Transplant-Composite Risk (HCT-CR): A Novel Predictor of Prognosis in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

    Transplantation Proceedings, 2021

    DOI 10.1016/j.transproceed.2021.06.017 PMID 34246474 Quelle: OpenAlex

  24. Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients

    Hematology, 2020

    DOI 10.1080/16078454.2020.1738097 PMID 32153257 11 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  25. Comparison of Post-Remission Strategies in Acute Myeloid Leukemia: Autologous Hematopoietic Stem Cell Transplantation versus Consolidation Chemotherapy

    Hematology Reports, 2020

    DOI 10.4081/hr.2020.8380 PMID 33324478 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  26. Hematopoietik Kök Hücre Nakli Olmuş Hastalarda JC Virüs Pozitifliğinin Gerçek-Zamanlı Polimeraz Zincir Reaksiyonu ile Araştırılması

    Flora the Journal of Infectious Diseases and Clinical Microbiology, 2020

    DOI 10.5578/flora.68466 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  27. The Eventual Role of Donor and Recipient Vitamin D Levels in Allogeneic Hematopoetic Stem Cell Transplant Setting

    Bursa Uludag University - AVESIS, 2020

    Quelle: OpenAlex

  28. Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey

    Blood, 2019

    DOI 10.1182/blood-2019-128743 Frei zugänglicher VolltextQuelle: OpenAlex

  29. Efficacy of manual lymph drainage plus exercise on range of motion and flexibility in refractory chronic cutaneous graft-versus-host disease: A case report

    Current Research in Translational Medicine, 2019

    DOI 10.1016/j.retram.2019.11.001 PMID 31761680 3 Zitationen (OpenAlex) Quelle: OpenAlex

  30. Hematolojik Maligniteli Hastalarda Nadir ve Mortal Bir Enfeksiyon Etkeni: Saprochaete capitata

    Mikrobiyoloji Bulteni, 2016

    DOI 10.5578/mb.28152 PMID 28124967 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex